The mandates cover:
- The purchase of not more than 4,250,000 series A shares, whereof a maximum 3,500,000 may be transferred to personnel stock option holders under the Performance Stock Option Plan 2013.
- The purchase of not more than 70,000 series A shares, later to be sold on the market in connection with payment to Board members who have opted to receive synthetic shares as part of their board fee.
- The sale of not more than 55,000 series A shares to cover costs related to previously issued synthetic shares to Board members.
- The sale of maximum 8,100,000 series A and B shares currently held by the company, for the purpose of covering costs of fulfilling obligations related to the performance stock option plans 2008, 2009 and 2010.
Repurchases and sales are subject to market conditions, regulatory restrictions and the capital structure at any given time.
The number of issued shares is presently 1,229,613,104, whereof 839,394,096 series A shares and 390,219,008 series B shares.